A trou­bled time­line

The News-Times (Sunday) - - Sunday Business -

Since Pur­due Pharma’s top-sell­ing drug, OxyCon­tin, went on sale in the mid-1990s, it has faced grow­ing le­gal and reg­u­la­tory scru­tiny.

1995: U.S. Food and Drug Ad­min­is­tra­tion ap­proves Pur­due Pharma’s OxyCon­tin. 1996: OxyCon­tin goes on mar­ket. 2001: OxyCon­tin an­nual sales sur­pass $1 bil­lion. 2003: U.S. Gov­ern­ment Ac­count­abil­ity Of­fice de­tails OxyCon­tin’s role in opi­oid cri­sis and out­lines du­bi­ous Pur­due mar­ket­ing prac­tices. The com­pany re­ceives warn­ing let­ter from FDA about its mar­ket­ing prac­tices. 2007: Com­pany and three top ex­ec­u­tives plead guilty to fraud­u­lent mar­ket­ing and agree to com­bined $635 mil­lion penalty to fed­eral and state au­thor­i­ties. 2010: FDA ap­proves re­for­mu­lated ver­sion of OxyCon­tin. 2015: Pur­due reaches $24 mil­lion set­tle­ment with state of Ken­tucky re­lated to false mar­ket­ing claims. 2016: Con­necti­cut joins coali­tion of 42 states in­ves­ti­gat­ing Pur­due and other opi­oid mak­ers and dis­trib­u­tors. 2017: Law­suits mount against com­pany. Thir­teen states and many lo­cal and county gov­ern­ments file lit­i­ga­tion. Depart­ment of Jus­tice launches in­ves­ti­ga­tion of Pur­due.

2018: Lit­i­ga­tion against Pur­due con­tin­ues to mount. Eigh­teen states sue. To­tal number of law­suits against com­pany sur­passes 1,000.

Source: States' at­tor­neys gen­eral of­fices

More than half of Amer­i­can states have filed law­suits against Pur­due Pharma in the past three years. Have not filed a suit against Pur­due Have filed a suit against Pur­due

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.